Clinical Trials Logo

Clinical Trial Summary

With the new reimbursement criteria, we want:

To describe the average treatment duration of patients with Enbrel expressed as a number of weeks/year.

To describe the number of patients who receive continuous treatment To describe the number of patients who receive intermittent treatment To describe the number of weeks off treatment


Clinical Trial Description

100 patients will be followed for at least 1 year ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01557283
Study type Observational
Source Pfizer
Contact
Status Completed
Phase N/A
Start date September 2011
Completion date June 2013

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06299982 - An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO Phase 3